GlycoMimetics Inc.

NASDAQ: GLYC · Real-Time Price · USD
15.71
-0.44 (-2.72%)
At close: Jul 02, 2025, 3:58 PM

GlycoMimetics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-37.88M -36.9M -46.69M -63.43M
Depreciation & Amortization
35.17K 153.3K 207.15K 264.6K
Stock-Based Compensation
4.77M 3.56M 3.86M 6.09M
Other Working Capital
1.7M -2.46M -3.52M -1.18M
Other Non-Cash Items
814.48K 864.87K 828.51K 749.04K
Deferred Income Tax
n/a n/a n/a 2.17K
Change in Working Capital
1.16M -2.56M -4.66M -1.17M
Operating Cash Flow
-31.1M -34.88M -46.46M -57.49M
Capital Expenditures
-9.97K -21.39K -84.19K -14.94K
Cash Acquisitions
30K n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
20.03K -21.39K -84.19K -14.94K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 116.5K n/a 25.03K
Financial Cash Flow
5.4K 28.82M 4.16M 10.72M
Net Cash Flow
-31.07M -6.08M -42.38M -46.78M
Free Cash Flow
-31.11M -34.9M -46.54M -57.5M